NVCR vs. EBS
Compare and contrast key facts about NovoCure Limited (NVCR) and Emergent BioSolutions Inc. (EBS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVCR or EBS.
Correlation
The correlation between NVCR and EBS is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
NVCR vs. EBS - Performance Comparison
Loading data...
Key characteristics
NVCR:
87.23%
EBS:
319.66%
NVCR:
-8.05%
EBS:
-11.16%
NVCR:
-2.14%
EBS:
-11.16%
Fundamentals
NVCR:
$1.94B
EBS:
$307.00M
NVCR:
-$1.51
EBS:
-$3.60
NVCR:
-0.47
EBS:
1.55
NVCR:
3.12
EBS:
0.29
NVCR:
5.35
EBS:
0.64
NVCR:
$621.71M
EBS:
$737.80M
NVCR:
$479.70M
EBS:
$181.00M
NVCR:
-$105.45M
EBS:
-$26.50M
Returns By Period
NVCR
N/A
N/A
N/A
N/A
N/A
N/A
EBS
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVCR vs. EBS — Risk-Adjusted Performance Rank
NVCR
EBS
NVCR vs. EBS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
NVCR vs. EBS - Dividend Comparison
Neither NVCR nor EBS has paid dividends to shareholders.
Drawdowns
NVCR vs. EBS - Drawdown Comparison
The maximum NVCR drawdown since its inception was -8.05%, smaller than the maximum EBS drawdown of -11.16%. Use the drawdown chart below to compare losses from any high point for NVCR and EBS. For additional features, visit the drawdowns tool.
Loading data...
Volatility
NVCR vs. EBS - Volatility Comparison
Loading data...
Financials
NVCR vs. EBS - Financials Comparison
This section allows you to compare key financial metrics between NovoCure Limited and Emergent BioSolutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVCR vs. EBS - Profitability Comparison
NVCR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, NovoCure Limited reported a gross profit of 116.47M and revenue of 154.99M. Therefore, the gross margin over that period was 75.2%.
EBS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a gross profit of 71.30M and revenue of 189.30M. Therefore, the gross margin over that period was 37.7%.
NVCR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, NovoCure Limited reported an operating income of -37.87M and revenue of 154.99M, resulting in an operating margin of -24.4%.
EBS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported an operating income of -9.50M and revenue of 189.30M, resulting in an operating margin of -5.0%.
NVCR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, NovoCure Limited reported a net income of -34.32M and revenue of 154.99M, resulting in a net margin of -22.1%.
EBS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a net income of -31.30M and revenue of 189.30M, resulting in a net margin of -16.5%.